Considering the significance of the anti-tumor response by CD8+ T lymphocytes, not merely the efficacy of T cells matters, the component especially the proportionality of mature T cells activated by MHC and co-stimulator should be focused on [9]. This evidence concerns the gene CD8A and neoplasm.